Cargando…
Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions
OBJECTIVES: We aim to describe rates and risk factors of Hepatitis C Virus (HCV) diagnoses, follow-up HCV testing and HCV seroconversion from 2004–2011 in a cohort of HIV-positive persons in Spain. METHODS: CoRIS is a multicentre, open and prospective cohort recruiting adult HIV-positive patients na...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280214/ https://www.ncbi.nlm.nih.gov/pubmed/25549224 http://dx.doi.org/10.1371/journal.pone.0116226 |
_version_ | 1782350826322264064 |
---|---|
author | Sobrino-Vegas, Paz Monge Corella, Susana Serrano-Villar, Sergio Gutiérrez, Félix Blanco, José Ramón Santos, Ignacio del Romero, Jorge Segura, Ferrán Portilla, Joaquín Guillén, Santiago Moreno del Amo, Julia |
author_facet | Sobrino-Vegas, Paz Monge Corella, Susana Serrano-Villar, Sergio Gutiérrez, Félix Blanco, José Ramón Santos, Ignacio del Romero, Jorge Segura, Ferrán Portilla, Joaquín Guillén, Santiago Moreno del Amo, Julia |
author_sort | Sobrino-Vegas, Paz |
collection | PubMed |
description | OBJECTIVES: We aim to describe rates and risk factors of Hepatitis C Virus (HCV) diagnoses, follow-up HCV testing and HCV seroconversion from 2004–2011 in a cohort of HIV-positive persons in Spain. METHODS: CoRIS is a multicentre, open and prospective cohort recruiting adult HIV-positive patients naïve to antiretroviral therapy. We analysed patients with at least one negative and one follow-up HCV serology. Incidence Rates (IR) were calculated and multivariate Poisson regression was used to estimate adjusted Rates Ratios (aIRR). RESULTS: Of 2112 subjects, 53 HCV diagnoses were observed, IR = 0.93/100py (95%CI: 0.7–1.2). IR increased from 0.88 in 2004–05 to 1.36 in 2010–11 (aIRR = 1.55; 95%CI: 0.37–6.55). In men who have sex with men (MSM) from 0.76 to 1.10 (aIRR = 1.45; 95%CI: 0.31–6.82); in heterosexual (HTX) subjects from 1.19 to 1.28 (aIRR = 1.08; 95%CI: 0.11–10.24). HCV seroconversion rates decreased from 1.77 to 0.65 (aIRR = 0.37; 95%CI: 0.12–1.11); in MSM from 1.06 to 0.49 (aIRR = 0.46; 95%CI: 0.09–2.31); in HTX from 2.55 to 0.59 (aIRR = 0.23; 95%CI: 0.06–0.98). HCV infection risk was higher for injecting drug users (IDU) compared to HTX (aIRR = 9.63;95%CI: 2.9–32.2); among MSM, for subjects aged 40–50 compared to 30 or less (IRR = 3.21; 95%CI: 1.7–6.2); and among HTX, for female sex (aIRR = 2.35; 95%CI: 1.03–5.34) and <200 CD4-count (aIRR = 2.39; 95%CI: 0.83–6.89). CONCLUSION: We report increases in HCV diagnoses rates which seem secondary to intensification of HCV follow-up testing but not to rises in HCV infection rates. HCV IR is higher in IDU. In MSM, HCV IR increases with age. Among HTX, HCV IR is higher in women and in subjects with impaired immunological situation. |
format | Online Article Text |
id | pubmed-4280214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-42802142015-01-07 Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions Sobrino-Vegas, Paz Monge Corella, Susana Serrano-Villar, Sergio Gutiérrez, Félix Blanco, José Ramón Santos, Ignacio del Romero, Jorge Segura, Ferrán Portilla, Joaquín Guillén, Santiago Moreno del Amo, Julia PLoS One Research Article OBJECTIVES: We aim to describe rates and risk factors of Hepatitis C Virus (HCV) diagnoses, follow-up HCV testing and HCV seroconversion from 2004–2011 in a cohort of HIV-positive persons in Spain. METHODS: CoRIS is a multicentre, open and prospective cohort recruiting adult HIV-positive patients naïve to antiretroviral therapy. We analysed patients with at least one negative and one follow-up HCV serology. Incidence Rates (IR) were calculated and multivariate Poisson regression was used to estimate adjusted Rates Ratios (aIRR). RESULTS: Of 2112 subjects, 53 HCV diagnoses were observed, IR = 0.93/100py (95%CI: 0.7–1.2). IR increased from 0.88 in 2004–05 to 1.36 in 2010–11 (aIRR = 1.55; 95%CI: 0.37–6.55). In men who have sex with men (MSM) from 0.76 to 1.10 (aIRR = 1.45; 95%CI: 0.31–6.82); in heterosexual (HTX) subjects from 1.19 to 1.28 (aIRR = 1.08; 95%CI: 0.11–10.24). HCV seroconversion rates decreased from 1.77 to 0.65 (aIRR = 0.37; 95%CI: 0.12–1.11); in MSM from 1.06 to 0.49 (aIRR = 0.46; 95%CI: 0.09–2.31); in HTX from 2.55 to 0.59 (aIRR = 0.23; 95%CI: 0.06–0.98). HCV infection risk was higher for injecting drug users (IDU) compared to HTX (aIRR = 9.63;95%CI: 2.9–32.2); among MSM, for subjects aged 40–50 compared to 30 or less (IRR = 3.21; 95%CI: 1.7–6.2); and among HTX, for female sex (aIRR = 2.35; 95%CI: 1.03–5.34) and <200 CD4-count (aIRR = 2.39; 95%CI: 0.83–6.89). CONCLUSION: We report increases in HCV diagnoses rates which seem secondary to intensification of HCV follow-up testing but not to rises in HCV infection rates. HCV IR is higher in IDU. In MSM, HCV IR increases with age. Among HTX, HCV IR is higher in women and in subjects with impaired immunological situation. Public Library of Science 2014-12-30 /pmc/articles/PMC4280214/ /pubmed/25549224 http://dx.doi.org/10.1371/journal.pone.0116226 Text en © 2014 Sobrino-Vegas et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sobrino-Vegas, Paz Monge Corella, Susana Serrano-Villar, Sergio Gutiérrez, Félix Blanco, José Ramón Santos, Ignacio del Romero, Jorge Segura, Ferrán Portilla, Joaquín Guillén, Santiago Moreno del Amo, Julia Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions |
title | Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions |
title_full | Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions |
title_fullStr | Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions |
title_full_unstemmed | Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions |
title_short | Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions |
title_sort | incidence of hepatitis c virus (hcv) in a multicenter cohort of hiv-positive patients in spain 2004–2011: increasing rates of hcv diagnosis but not of hcv seroconversions |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280214/ https://www.ncbi.nlm.nih.gov/pubmed/25549224 http://dx.doi.org/10.1371/journal.pone.0116226 |
work_keys_str_mv | AT sobrinovegaspaz incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions AT mongecorellasusana incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions AT serranovillarsergio incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions AT gutierrezfelix incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions AT blancojoseramon incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions AT santosignacio incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions AT delromerojorge incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions AT seguraferran incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions AT portillajoaquin incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions AT guillensantiagomoreno incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions AT delamojulia incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions AT incidenceofhepatitiscvirushcvinamulticentercohortofhivpositivepatientsinspain20042011increasingratesofhcvdiagnosisbutnotofhcvseroconversions |